Overview

HepGene is dedicated to radically improving the detection, diagnosis and treatment of metabolic disease. Our flagship intelli-HEP liquid biopsy program is uniquely positioned to address clinically urgent unmet needs across the entire care continuum for non-alcoholic fatty liver disease (NAFL/NASH). Earlier detection. Easier diagnosis. Better treatment.